POSTERS ASCO 2024

Cáncer gastrointestinal

Gastroesofágico, pancreático y hepatobiliar

Cabozantinib plus atezolizumab in patients with advanced and progressive neuroendocrine neoplasms (NENs): A prospective multi-cohort basket phase II trial (CABATEN / GETNE-T1914).

Cabozantinib plus atezolizumab in patients with advanced and progressive neuroendocrine neoplasms (NENs): A prospective multi-cohort basket phase II trial (CABATEN / GETNE-T1914).

Abstract: 4128 Poster Bd #: 108

Poster

Descargar

Autor
Jorge Hernando, MD, PhD

Medical Oncology Department. Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO)

Compartir:

Una iniciativa científica de:

eco clover

Con el patrocinio de:

REGENERON